close
close

Contact:
Communication office
[email protected]
850-245-4111

Tallahassee, Florida – Contrary to popular misinformation, the vaccine ordering process in Florida has not changed. Ordering the COVID-19 vaccine, including for the age group 6 months to 5 years, has always been available to healthcare providers. After Emergency Use Permit released today, June 17, 2022, registered providers can order COVID-19 vaccines for the newest authorized age groups through SHOTS Florida.

For that Permission for emergency use, the following are now allowed:

  • Moderna COVID-19 vaccine 2-dose primary series for children aged 6 months to 5 years (25 mcg),
  • Moderna COVID-19 vaccine 2-dose primary series for children aged 6 to 11 years (50 mcg),
  • Moderna COVID-19 Vaccine 2 Doses Primary Series for Adolescents 12 to 17 Years (100 mcg)
  • Pfizer 3-dose series for children aged 6 months to 4 years (3 mcg).

Florida’s decision not to participate in the burdensome vaccine pre-order process has never prevented the vaccine from being ordered or stocked in Florida.

Vaccines will be delivered as early as next week to:

  • Pharmacy partners (CVS, Walgreen’s, Publix),
  • Federally Qualified Health Centers (FQHC),
  • Healthcare providers placing orders through SHOTS Florida.

Florida Department of Health (department) does not recommend pediatric COVID-19 vaccines for healthy children. Currently available data on COVID-19 vaccines for children aged 6 months to 5 years are insufficient to assess risks and benefits.

The Department encourages parents to discuss vaccination decisions directly with their children’s health care providers, which is why providers are instructed to order the vaccines they need.

Last year, the State of Florida shifted its COVID-19 response to effective local efforts. COVID-19 is endemic and health care providers are responsible for managing patient care. All healthcare providers are expected to be aware of evolving COVID-19 prevention and treatment options, including:

  • Evusheld is a long-acting monoclonal antibody for pre-exposure prophylaxis for immunocompromised patients, including cancer patients and/or transplant patients.
  • Paxlovid as well as Molnupiravir oral antivirals are available to treat COVID-19,
  • bebtelovimab is a monoclonal antibody treatment for patients who test positive for COVID-19 at high risk.

Health care providers can find more information about these drugs and where to find them. here.

About the Florida Department of Health

Department accredited at the national level Council for Public Health Accreditationworks to protect, promote, and improve the health of all Florida residents through a comprehensive state, county, and community effort.

Follow us on Twitter at @HealthyFla and beyond facebook. For more information about the Florida Department of Health, visit www.FloridaHealth.gov.

Subscribe to mailing list

By them

Leave a Reply

Your email address will not be published.